Clinical Trial: A Study of Short-Course Radiotherapy Followed by Subcutaneous Toripalimab Plus Capecitabine in Patients Aged 75 Years or Older With Locally Advanced Rectal Cancer (China)

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study of Short-Course Radiotherapy Followed by Subcutaneous Toripalimab Plus Capecitabine in Patients Aged 75 Years or Older With Locally Advanced Rectal Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131558

Registration Time: 2026/09/03

Type: Interventional study

Primary Sponsor: Peking University Third Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341718

Published by HT Digital Content Services with permission from Health Daily Digest....